Autoimmune Technologies entered the industry of Medical Research in 1995 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5413802, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Russell Wilson, President by calling (504) 529-9944 during business hours. You can also write to the business’ Single Location at 1010 Common St # 1705, New Orleans, Louisiana LA 70112. You can also visit the company’s website at autoimmune.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Autoimmune Technologies |
Representative: | Russell Wilson, President |
Place of Business: | 1010 Common St # 1705, New Orleans, LA 70112 |
Contact Number: | (504) 529-9944 |
Website: | autoimmune.com |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 5413802 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1995 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Autoimmune Technologies is a company operating from Orleans, Louisiana providing professional Medical Research and relevant B2B variables. It was founded in 1995 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5413802 as Medical Research.
With a current employee count of 1 to 4, Autoimmune Technologies has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Russell Wilson, President at (504) 529-9944 for related queries, or to locate its Single Location using the coordinates 29.953837,-90.073006.
The Single Location can also be found at the street address 1010 Common St # 1705 in New Orleans, Louisiana 70112 and can be engaged online through the company website at autoimmune.com, the company Twitter , and Facebook page .